|
Rosuvastatin Clinical Trials
3 actively recruiting trials across 2 locations
Also known as: Rosuvastatin 10 mg, Rosuvastatin 20 mg
Pipeline
Phase 2: 1Phase 4: 2
Top Sponsors
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
- Nanjing First Hospital, Nanjing Medical University1
- Massachusetts General Hospital1
Indications
- Heart Disease2
- Coronary Artery Disease2
- Cirrhosis Alcoholic1
- Cirrhosis Infectious1
- Cirrhosis Advanced1
Other1 trial
La Jolla, California1 trial
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
University of California San Diego NAFLD Research Center
Phase 2
Boston, Massachusetts1 trial
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Intervention With Statin and Colchicine
Massachusetts General Hospital
Phase 4
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.